Become A Member

Introduction: Allergic rhinitis is defined as symptoms of sneezing, nasal pruritus, airflow obstruction, and mostly clear nasal discharge caused by IgE-mediated reactions against inhaled allergens and involving mucosal inflammation driven by type 2 helper T (Th2) cells. Indian study reported that prevalence of allergic rhinitis was 11·3% in children aged 6–7 years, and 24.4% in children aged 13–14 years. Material and Method: Total 60 patients were registered in the study. 30 in each group. Group A (Trial group)– In Group A, patients were given Kushtadi Taila Nasya, 2-2 drops/nostril twice a day for 7 days. Group B (Control Drug) – In Group B, patients were given Tila Taila Nasya, 2-2 drops/nostril twice a day for 7 days. Result:  Out of 30 patients of group A, 26 patients got relief while 4 didn’t get relief and 23 patients out of 30 patients of group B got relief while 7 patients were not relieved. Chi-square test at 5% level of significance indicates that the relief rate group A and group B are not significantly different (P-value = 0.05). Conclusion: The study can be concluded by saying that Kushtadi Taila Nasya formulation is better choice of treatment in case of Kshavathu and Tila Taila Nasya formulation also can be adopted by considering the convenience of the patients.

KEYWORDS: Kushtahadi Taila, Kshavathu, Allergic Rhinitis